Penumbra

PEN74

$244.84arrow_drop_up1.83%$4.41

PEN74

$244.84

arrow_drop_up1.83%$4.41

Performance History

Key Stats
Open	$240.00
Prev. Close	$240.49
EPS	0.88
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	234.60	245.21
52 Week Range	148.00	277.34

Ratios







EPS	0.88

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Penumbra (PEN)

Penumbra Inc is a medical device company that focuses on the development, manufacturing, and marketing of innovative and minimally invasive medical devices. The company's products are designed to assist in the diagnosis and treatment of various neurological, vascular, and peripheral conditions. With a strong commitment to improving patient outcomes, Penumbra has established itself as a leader in the field of medical devices. The company's stock price history shows a consistent upward trend, demonstrating investor confidence in its products and growth potential.

In terms of market cap, Penumbra Inc is a well-established player with a strong presence in the medical device industry. The company's market cap reflects its overall value and market position. When comparing Penumbra Inc to its industry peers, it is important to consider factors such as revenue growth, profitability, and market share. Penumbra Inc has consistently outperformed its industry, demonstrating its ability to stay ahead of the competition.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Adam Elsesser
Headquarters: Alameda
Employees: 3900
Exchange: NYSE

Keep an eye on Penumbra

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Penumbra 's (PEN) price per share?

The current price per share for Penumbra (PEN) is $244.84. The stock has seen a price change of $4.41 recently, indicating a 1.84% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Penumbra (PEN)?

For Penumbra (PEN), the 52-week high is $277.34, which is 13.27% from the current price. The 52-week low is $148, the current price is 65.43% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Penumbra (PEN) a growth stock?

Penumbra (PEN) has shown an average price growth of -3.66% over the past three years. It has received a score of 45 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Penumbra as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Penumbra (PEN) stock price performance year to date (YTD)?

As of the latest data, Penumbra (PEN) has a year-to-date price change of 0.03%. Over the past month, the stock has experienced a price change of 18.54%. Over the last three months, the change has been 21.17%. Over the past six months, the figure is 26.43%. Looking at a longer horizon, the five-year price change stands at 42.49%.

help

Is Penumbra (PEN) a profitable company?

Penumbra (PEN) has a net income of $90.95M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 64.49% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 11.75% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.06B, with a revenue growth rate of 24.95%, providing insight into the company's sales performance and growth. The gross profit is $682.64M. Operating income is noted at $73.55M. Furthermore, the EBITDA is $102.64M.

help

What is the market capitalization of Penumbra (PEN)?

Penumbra (PEN) has a market capitalization of $9.4B. The average daily trading volume is 243.56, indicating the stock's liquidity and investor engagement.